AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DIMERIX LTD

0.230

0.000

Volume:271.61K

Turnover:62.83K

Market Cap:138.09M

PE:-4.63

High:0.235

Open:0.235

Low:0.225

Close:0.230

52wk High:0.665

52wk Low:0.157

Shares:600.40M

Float Shares:467.70M

Volume Ratio:0.32

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.050

EPS(LYR):-0.050

ROE:-594.54%

ROA:-29.36%

PB:-9.36

PE(LYR):-4.63

Loading ...

Overview Company News Filings

Concept

Novel Coronavirus Treatment+1.12%

Pharmaceutical Companies+1.43%

Capital Flow

Inflow:

Outflow:

News

Dimerix Receives AU$17 Million in Proceeds After Completing Initial Drawdown Under Non-Dilutive Funding Facility

MT Newswires Live

Dimerix Ltd-Waiver of Listing Rule 10.1 Granted

THOMSON REUTERS

Dimerix - Waiver Permits Security Grant to Skiptan Entities Without Shareholder Approval

THOMSON REUTERS

Australia's Dimerix Rises on Patent Approval in Mexico

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/DXB.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DXB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","market":"AU","secType":"STK","nameCN":"DIMERIX LTD","latestPrice":0.23,"timestamp":1790748720000,"preClose":0.23,"halted":0,"volume":271613,"delay":0,"changeRate":0,"nameEN":"DIMERIX LTD","floatShares":467696880,"shares":600396776,"eps":-0.0497,"marketStatus":"Not Yet Opened","change":0,"latestTime":"09-30 16:12:00 AEST","open":0.235,"high":0.235,"low":0.225,"amount":62830,"amplitude":0.043478,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0497,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.23,"openAndCloseTimeList":[[1790726400000,1790748000000]],"volumeRatio":0.3242399288665511,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"DXB.AU","preClose":0.23,"auctionPrice":0.235,"auctionVolume":90,"auctionTime":1790807292830,"referenceTime":1790764203089,"auction":1,"marketStatus":"盘前竞价","timestamp":1790807292830}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","floatShares":467696880,"roa":"-29.36%","roe":"-594.54%","lyrEps":-0.0497,"volumeRatio":0.3242399288665511,"shares":600396776,"dividePrice":0,"high":0.235,"amplitude":0.043478,"preClose":0.23,"low":0.225,"week52Low":0.157,"pbRate":"-9.36","psRate":"21.73","week52High":0.665,"institutionHeld":0,"latestPrice":0.23,"eps":-0.0497,"divideRate":0,"volume":271613,"delay":0,"ttmEps":-0.0497,"open":0.235,"prevYearClose":0.55,"prevWeekClose":0.225,"prevMonthClose":0.23,"prevQuarterClose":0.23,"fiveDayClose":0.235,"twentyDayClose":0.29,"sixtyDayClose":0.24,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DXB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DXB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DXB.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669736001","title":"Dimerix Receives AU$17 Million in Proceeds After Completing Initial Drawdown Under Non-Dilutive Funding Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2669736001","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669736001?lang=en_us&edition=fundamental","pubTime":"2026-09-23 08:17","pubTimestamp":1790122651,"startTime":"0","endTime":"0","summary":"Dimerix  confirmed that it completed an initial drawdown under its AU$34 million non-dilutive funding facility, receiving gross proceeds of AU$17 million, according to a Wednesday Australian bourse filing.The remaining AU$17 million is available for drawdown at the firm's election until March 31, 2027, subject to facility terms, the company said.It also confirmed that it was funded through to the delivery of the Action3 phase three trial of its DMX-200 treatment candidate in patients with focal segmental glomerulosclerosis, a rare kidney disease, and continued advancement of the phase two trial of DMX-652 in acute kidney injury.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DXB.AU","BK7501","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669115427","title":"Dimerix Ltd-Waiver of Listing Rule 10.1 Granted","url":"https://stock-news.laohu8.com/highlight/detail?id=2669115427","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669115427?lang=en_us&edition=fundamental","pubTime":"2026-09-22 13:46","pubTimestamp":1790055990,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUE3SH9TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","DXB.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669115404","title":"Dimerix - Waiver Permits Security Grant to Skiptan Entities Without Shareholder Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2669115404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669115404?lang=en_us&edition=fundamental","pubTime":"2026-09-22 13:46","pubTimestamp":1790055990,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUE3SH9TS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","DXB.AU","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667632159","title":"Australia's Dimerix Rises on Patent Approval in Mexico","url":"https://stock-news.laohu8.com/highlight/detail?id=2667632159","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667632159?lang=en_us&edition=fundamental","pubTime":"2026-09-14 11:59","pubTimestamp":1789358350,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Dimerix rises on patent approval in Mexico** Shares of Australia's DimerixDXB.AXrise as much as 10% to A$0.275, marking their biggest pct gain since August 20** Clinical-stage biopharmaceutical company says Mexico has granted a patent for DMX-652, a drug candidate for acute kidney injury** The patent expands protection for DMX-652 in Mexico, one of Latin America's largest pharmaceutical markets** Co says the approval strengthens the commercial potential of DMX-652, following a similar approval for the drug in U.S.** YTD down 53.6%, including the session's moves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N45604Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXB.AU","BK7501","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":12,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DXB.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Novel Coronavirus Treatment","id":"package_au_concept_xgzlg","bkCode":"BK7501","changeRate":0.011197},{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.014295}]}}